Ingevity Corporation
NYSE:NGVTChemicals - Specialty
+$0.81 today
- Market cap
- $1.97B
- Beta
- 1.19
- P/E (TTM)
- -20.0
- EPS (TTM)
- -$3.62
Volume 0.37M
Average 0.26M
NGVT Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Ingevity CorporationNYSE: NGVT
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization remains negative
Q3 FY2026 depreciation & amortization was $0, compared with $28M a year earlier. Trailing-twelve-month depreciation & amortization was $72.6M. Over 3 fiscal years it compounded at -0.7% a year.
Context
- Depreciation & amortization amounted to 9.1% of revenue in FY2025, up 1.4 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly depreciation & amortization holds near $0 or moves back toward the trailing-twelve-month quarterly average of $18.15M.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 106.4M USD
- Year-over-year change
- -1.8%
- 4-year CAGR
- -0.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 106.4M | -1.8% |
| FY2024 | 2024-12-31 | 108.3M | -11.8% |
| FY2023 | 2023-12-31 | 122.8M | +12.9% |
| FY2022 | 2022-12-31 | 108.8M | -1.0% |
| FY2021 | 2021-12-31 | 109.9M | — |
Depreciation & Amortization vs competitors
How NGVT compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -30.0% is the 7th highest of 11, against a peer median of -22.1%.
- Depreciation & amortization amounts to 6.4% of revenue for NGVT, versus a peer median of 4.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $259.5M USD | -50.2% | -4.5% | 3.9% | |
| LTM Jun 2026 | $238M USD | -29.2% | +5.3% | 4.1% | |
| LTM Jun 2026 | $191M USD | -33.2% | -0.6% | 10.4% | |
| LTM Mar 2026 | $168.4M USD | -32.4% | +1.4% | 4.9% | |
| LTM Apr 2026 | $100.4M USD | -5.3% | +0.5% | 4.7% | |
| LTM Sep 2026 | $75.99M USD | -15.0% | +5.1% | 3.8% | |
| LTM Sep 2026 | $72.6M USD | -30.0% | -0.7% | 6.4% | |
AAUCAllied Gold Corporation | LTM Jun 2026 | $70.96M USD | +12.5% | +10.7% | 4.8% |
| LTM Jun 2026 | $41.5M USD | -5.7% | +2.8% | 2.3% | |
ELVRElevra Lithium Limited | FY2025 | A$34.26M AUD | -14.7% | +79.0% | 16.5% |
| LTM Sep 2026 | CA$1.6M CAD | -60.7% | -1.6% | — | |
| Peer median (excluding NGVT) | — | -22.1% | +2.1% | 4.7% | |
Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.39B | 1.67B | 1.69B | 1.41B | 1.17B |
| Cost of Revenue | 878.7M | 1.1B | 1.22B | 951.7M | 706.1M |
| Gross Profit | 512.8M | 570.1M | 471.9M | 454.7M | 461.5M |
| Gross Margin | 36.9% | 34.2% | 27.9% | 32.3% | 39.5% |
| Research & Development | 26.3M | 30.3M | 31.8M | 28.1M | 28.4M |
| Selling, General & Admin | 179.3M | 198.8M | 183.7M | 166.7M | 171.2M |
| Operating Expenses | 205.6M | 229.1M | 215.5M | 194.8M | 199.6M |
| Depreciation & Amortization | 109.9M | 108.8M | 122.8M | 108.3M | 106.4M |
| EBITDA | 324.4M | 440.2M | 206M | (329.5M) | 37.4M |
| EBITDA Margin | 23.3% | 26.4% | 12.2% | -23.4% | 3.2% |
| Operating Income | 307.2M | 341M | 256.4M | 259.9M | 261.9M |
| Operating Margin | 22.1% | 20.4% | 15.2% | 18.5% | 22.4% |
| Interest Income | 4M | 5.8M | 6.3M | 6.9M | 4.4M |
| Interest Expense | 51.7M | 61.8M | 93.3M | 97.8M | 77.1M |
| Other Income / Expenses | (144.4M) | (71.4M) | (266.5M) | (795.5M) | (404M) |
| Income Before Tax | 162.8M | 269.6M | (10.1M) | (535.6M) | (142.1M) |
| Pre-Tax Margin | 11.7% | 16.2% | -0.6% | -38.1% | -12.2% |
| Income Tax Expense | 44.7M | 58M | (4.7M) | (105.3M) | 8.2M |
| Net Income | 118.1M | 211.6M | (5.4M) | (430.3M) | (167.1M) |
| Net Margin | 8.5% | 12.7% | -0.3% | -30.6% | -14.3% |
| EPS (Basic) | 2.97 | 5.50 | (0.15) | (11.85) | (4.61) |
| EPS (Diluted) | 2.95 | 5.50 | (0.15) | (11.85) | (4.61) |
| Weighted Avg Shares | 39.8M | 38.47M | 36.5M | 36.32M | 36.2M |
| Weighted Avg Shares (Diluted) | 40.06M | 38.47M | 36.5M | 36.32M | 36.2M |
Ingevity Corporation
NYSE:NGVT
Intrinsic Alpha fair value
Locked
Current Price
$58.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.